Phys.Org (Dec. 7) -- In an interdisciplinary university-industry collaboration led by BioE assistant professor Dipanjan Pan has discovered a novel method for repositioning an FDA-approved anti-cancer compound so it can specifically target liver cancer tumors. A “triple attack” technique combining chemotherapy, thermal ablation, and hyperthermia provided a highly targeted, yet minimally invasive approach. Also: Science Daily (Dec. 7), Nanowerk (Dec. 7), ScienceBlog (Dec. 7), The Engineer (UK, Dec. 8), News-Medical (Dec. 8), Engadget (Dec. 8), Gizmag (Dec. 8), Tech Times (Dec. 10), Gizmag (Dec. 10).